Biotech company Novoron to open Missoula branch in pursuit of cure for spinal injuries
A San Diego-based biotech company this week announced its plans to expand into Missoula, where it looks to open an office and build a team in its pursuit of curing injuries to the central nervous system.
Novoron Bioscience Teams with Expesicor to Develop Neuroregenerative Compounds for Epilepsy and Alzheimer’s Disease
Novoron Bioscience announced a strategic partnership today with Expesicor to develop Novoron’s novel compounds to treat epilepsy and neurodegenerative disorders.
The Johnson & Johnson Under 40 to Watch List: 6 Young Trailblazing Scientists
Johnson & Johnson recently identified six young scientists working toward the next great breakthroughs in healthcare. Novoron Bioscience's CEO & President, Dr. Travis Stiles, was named one of the six.
Dr. Stiles Named 2016 Catalyst by Biocom
Novoron's CEO & President, Dr. Travis Stiles, was recognized by Biocom: Life Science Association of California, in conjunction with the San Diego Venture Group, with a 2016 Catalyst Award.
Innovative Neuroscience Company Shows at RESI Challenge
Novoron Bioscience took home 3rd Prize in the 2016 Redefining Early Stage Investments (RESI) Innovation Challenge.
Novoron Recognized as Innovative San Diego Biotech
Our City San Diego named Novoron in the magazine’s list of 25 leading life science companies that could positively impact the San Diego economy in the coming years.
Xconomy Recognizes Novoron as San Diego Life Science Startup to Watch in 2016
